These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

958 related articles for article (PubMed ID: 27837775)

  • 1. The Gut Microbiota: The Gateway to Improved Metabolism.
    Martinez KB; Pierre JF; Chang EB
    Gastroenterol Clin North Am; 2016 Dec; 45(4):601-614. PubMed ID: 27837775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota and obesity: An opportunity to alter obesity through faecal microbiota transplant (FMT).
    Lee P; Yacyshyn BR; Yacyshyn MB
    Diabetes Obes Metab; 2019 Mar; 21(3):479-490. PubMed ID: 30328245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microbiota-gut-brain axis in obesity.
    Torres-Fuentes C; Schellekens H; Dinan TG; Cryan JF
    Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):747-756. PubMed ID: 28844808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota: a target for intervention in obesity.
    Sehgal K; Khanna S
    Expert Rev Gastroenterol Hepatol; 2021 Oct; 15(10):1169-1179. PubMed ID: 34329563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiome approaches to treat obesity in humans.
    Bianchi F; Duque ALRF; Saad SMI; Sivieri K
    Appl Microbiol Biotechnol; 2019 Feb; 103(3):1081-1094. PubMed ID: 30554391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the role of the human gut microbiome in overweight and obesity.
    McBurney MI; Cho CE
    Ann N Y Acad Sci; 2024 Oct; 1540(1):61-88. PubMed ID: 39283061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.
    Chowdhury M; Raj Chaudhary N; Kaur P; Goyal A; Sahu SK
    Infect Disord Drug Targets; 2024; 24(5):e160124225675. PubMed ID: 38317473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies to increase the efficacy of using gut microbiota for the modulation of obesity.
    Li J; Riaz Rajoka MS; Shao D; Jiang C; Jin M; Huang Q; Yang H; Shi J
    Obes Rev; 2017 Nov; 18(11):1260-1271. PubMed ID: 28742949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism.
    Amabebe E; Robert FO; Agbalalah T; Orubu ESF
    Br J Nutr; 2020 May; 123(10):1127-1137. PubMed ID: 32008579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiota as a therapeutic target for obesity: a scoping review.
    Santos-Paulo S; Costello SP; Forster SC; Travis SP; Bryant RV
    Nutr Res Rev; 2022 Dec; 35(2):207-220. PubMed ID: 34100344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota and metabolic syndrome.
    Festi D; Schiumerini R; Eusebi LH; Marasco G; Taddia M; Colecchia A
    World J Gastroenterol; 2014 Nov; 20(43):16079-94. PubMed ID: 25473159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet effects in gut microbiome and obesity.
    Chen J; He X; Huang J
    J Food Sci; 2014 Apr; 79(4):R442-51. PubMed ID: 24621052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
    Vemuri RC; Gundamaraju R; Shinde T; Eri R
    Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
    Barengolts E
    Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiota on biotics: probiotics, prebiotics, and synbiotics to optimize growth and metabolism.
    Edwards PT; Kashyap PC; Preidis GA
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G382-G390. PubMed ID: 32755308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts.
    da Silva TF; Casarotti SN; de Oliveira GLV; Penna ALB
    Crit Rev Food Sci Nutr; 2021; 61(2):337-355. PubMed ID: 32156153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of microbiome based strategies on anti-obesity.
    Chang CS; Ruan JW; Kao CY
    Kaohsiung J Med Sci; 2019 Jan; 35(1):7-16. PubMed ID: 30844145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
    Suk KT; Kim DJ
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.